Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA4 | P22748 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL893491 | 1.00 | ALDH1A1 (0.42) | ALDH1A1THRBMEN1KMT2ATSHR | |
| SCHEMBL360431 | 1.00 | ALDH1A1 (0.42) | ALDH1A1THRBMEN1KMT2ATSHR | |
| SCHEMBL15353382 | 0.95 | ALDH1A1 (0.39) | ALDH1A1THRBMEN1KMT2ATSHR | |
| SCHEMBL22129635 | 0.95 | ALDH1A1 (0.39) | ALDH1A1THRBMEN1KMT2ATSHR | |
| SCHEMBL7203910 | 0.95 | ALDH1A1 (0.39) | ALDH1A1THRBMEN1KMT2ATSHR | |
| SCHEMBL893629 | 0.95 | ALDH1A1 (0.39) | ALDH1A1THRBMEN1KMT2ATSHR | |
| SCHEMBL9119956 | 0.95 | ALDH1A1 (0.39) | ALDH1A1THRBMEN1KMT2ATSHR | |
| SCHEMBL789200 | 0.95 | ALDH1A1 (0.39) | ALDH1A1THRBMEN1KMT2ATSHR | |
| SCHEMBL16551763 | 0.95 | ALDH1A1 (0.39) | ALDH1A1THRBMEN1KMT2ATSHR | |
| SCHEMBL893497 | 0.95 | ALDH1A1 (0.39) | ALDH1A1THRBMEN1KMT2ATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12441823-B2 | Resin composition for optical shaping | KURARAY NORITAKE DENTAL INC. (JP) | 2025-10-14 | — | — | US | disclosed |
| US-12030970-B2 | Curable composition and stereolithographic resin composition comprising same | KURARAY CO., LTD. (JP) | 2024-07-09 | — | — | US | disclosed |
| EP-3900693-B1 | USE OF A RESIN COMPOSITION | KURARAY NORITAKE DENTAL INC (JP) | 2024-03-20 | — | — | EP | disclosed |
| US-11814454-B2 | Curable composition, and resin composition for stereolithography prepared therefrom | KURARAY CO., LTD. (JP) | 2023-11-14 | — | — | US | disclosed |
| US-20220325025-A1 | CURABLE COMPOSITION AND STEREOLITHOGRAPHIC RESIN COMPOSITION COMPRISING SAME | KURARAY CO., LTD. (JP) | 2022-10-13 | — | — | US | disclosed |
| US-20220242978-A1 | CURABLE COMPOSITION, AND RESIN COMPOSITION FOR STEREOLITHOGRAPHY PREPARED THEREFROM | KURARAY CO., LTD. (JP) | 2022-08-04 | — | — | US | disclosed |
| EP-3991958-A1 | CURABLE COMPOSITION AND STEREOLITHOGRAPHIC RESIN COMPOSITION COMPRISING SAME | Kuraray Co., Ltd. (JP) | 2022-05-04 | — | — | EP | disclosed |
| EP-3992216-A1 | CURABLE COMPOSITION, AND RESIN COMPOSITION FOR STEREOLITHOGRAPHY PREPARED THEREFROM | Kuraray Co., Ltd. (JP) | 2022-05-04 | — | — | EP | disclosed |
| US-20220041777-A1 | RESIN COMPOSITION FOR OPTICAL SHAPING | KURARAY NORITAKE DENTAL INC. (JP) | 2022-02-10 | — | — | US | disclosed |
| EP-3900693-A1 | RESIN COMPOSITION FOR OPTICAL MOLDING | Kuraray Noritake Dental Inc. (JP) | 2021-10-27 | — | — | EP | disclosed |
| WO-2020129736-A1 | RESIN COMPOSITION FOR OPTICAL MOLDING | クラレノリタケデンタル株式会社 | 2020-06-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11814454-B2 | Curable composition, and resin composition for stereolithography prepared therefrom | WASF2, COPE, ARCN1 | ALDH1A1 2089/4885THRB 4400/4885MEN1 3152/4885 |
| US-20220242978-A1 | CURABLE COMPOSITION, AND RESIN COMPOSITION FOR STEREOLITHOGRAPHY PREPARED THEREFROM | WASF2, COPE, ARCN1 | ALDH1A1 2089/4885THRB 4400/4885MEN1 3152/4885 |
| US-12030970-B2 | Curable composition and stereolithographic resin composition comprising same | ARL1, ASH2L, VCL | ALDH1A1 1097/4885THRB 3773/4885MEN1 2530/4885 |
| US-20220325025-A1 | CURABLE COMPOSITION AND STEREOLITHOGRAPHIC RESIN COMPOSITION COMPRISING SAME | ARL1, VCL, ARCN1 | ALDH1A1 1256/4885THRB 3833/4885MEN1 3773/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.